The impact of Suboxone's market exclusivity on cost of opioid use disorder treatment - McGee M, Chiu K, Moineddin R, Sud A.
BACKGROUND: Buprenorphine-naloxone is an essential part of the response to opioid poisoning rates in North America. Manipulating market exclusivity is a strategy manufacturers use to increase profitability, as evidenced by Suboxone in the USA. OBJE... (Source: SafetyLit)
Source: SafetyLit - January 20, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Overdose deaths involving buprenorphine did not proportionally increase with new flexibilities in prescribing
Federal study findings help understand effects of expanding access to treatment for opioid use disorder (Source: NIDA News)
Source: NIDA News - January 20, 2023 Category: Addiction Tags: Adults, News Release, COVID, Medical Consequences, Naloxone, Overdose, Prescription Drugs, Treatment, Treatment Research, Public Health, Treatment Source Type: news

US Settlement Signals Protections For People Taking Addiction Medicine
A former Tennessee correctional officer could receive $160,000 in back pay and damages after he was forced to resign for taking Suboxone to treat his opioid use disorder. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - January 19, 2023 Category: Science Source Type: news

Buprenorphine-Naloxone Appears Safe for Maternal Opioid Use Disorder
FRIDAY, Jan. 13, 2023 -- Buprenorphine-naloxone seems to be as safe for pharmacotherapy for maternal opioid use disorder as buprenorphine monotherapy, according to a study published online Jan. 11 in Acta Obstetricia et Gynecologica... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2023 Category: Pharmaceuticals Source Type: news

Maine ’s Prisons Taught Washington a Crucial Lesson in Fighting Opioids
Two inmates, likely ill from opiate detox, are monitored in the medical care portion of the Cumberland County jail in Portland, ME on July 2, 2015. | Linda Davidson / The Washington Post via Getty Images Krista Mahr is a health care reporter for POLITICO Pro covering public health and the CDC.…#lindadavidson #suboxone #ada #portland #reginalabelle #rikersisland #kristamahr #westvirginia #rulostrategies #zacharysmith (Source: Reuters: Health)
Source: Reuters: Health - January 8, 2023 Category: Consumer Health News Source Type: news

Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes
FRIDAY, Dec. 16, 2022 -- There is a higher risk for adverse dental outcomes associated with sublingual buprenorphine/naloxone compared with transdermal buprenorphine or oral naltrexone, according to a research letter published in the Dec. 13 issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 16, 2022 Category: Pharmaceuticals Source Type: news

Why Overdose Deaths Skyrocketed After Opioid Prescriptions Dropped
The American crackdown on the drugs that kicked off the modern opioid overdose epidemic—prescription opioids—largely succeeded. According to data released by the American Medical Association (AMA) on Sept. 8, opioid prescriptions have dropped in every state over the last decade, plummeting nearly 50% nationally. The effort to prevent overdose deaths, however, is an abject failure. Annual opioid overdose deaths more than tripled between 2010 and 2020, according to federal data. Drug overdose deaths over a 12-month period surpassed 100,000 for the first time in April 2021, with about 75% of those deaths involving...
Source: TIME: Health - September 19, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Drugs healthscienceclimate Source Type: news

FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a{ padding:0; } img{ -ms-interpolation-mode:bicubic; } table{ mso-table-lspace:0pt; mso-table-rspace:0pt; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } p,a,li,td,blockquote{ ...
Source: Johns Hopkins University and Health Systems Archive - August 10, 2022 Category: Nursing Source Type: news

The naloxone component of buprenorphine/naloxone: discouraging misuse, but at what cost? [editorial] - Gregg J, Hartley J, Lawrence D, Risser A, Blazes C.
Because opioid overdose deaths in the United States continue to rise, it is critical to increase patient access to buprenorphine, which treats opioid use disorder and reduces mortality. An underrecognized barrier to buprenorphine treatment (both for mainte... (Source: SafetyLit)
Source: SafetyLit - August 8, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Narcan Can Save an Opioid User ’ s Life. What to Know About the Drug
In the U.S., a record-setting 81,000 people died from overdoses involving opioids in 2021. But despite that grim number, there’s hope: medications like buprenorphine can treat opioid-use disorder, while harm-reduction methods such as needle exchanges can limit threats like infectious disease. There’s also another promising tool, naloxone. The emergency medication reverses the effects of opioids on the brain for 30 to 90 minutes, allowing people who have overdosed on an opioid to start breathing again. Distributed as an injectable drug or nasal spray sold under the brand name Narcan, it can save lives. For it to...
Source: TIME: Health - August 4, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Drugs healthscienceclimate Source Type: news

Dr Reddy's gearing up to get substantial slice of Revlimid generic opportunity in US
Revlimid is a top-selling cancer drug from Bristol Myers Squibb. Its generic form, called lenalidomide, is seen as Dr Reddy's most anticipated product for FY23. Last year, Revilimid had raked in $8 billion for Bristol Myers in US sales. It represents a sizable opportunity for Dr Reddy's which is facing pricing pressure and competition in certain key products, such as generics of Suboxone and Vasopressin. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 3, 2022 Category: Pharmaceuticals Source Type: news

Drug Overdose Deaths Rose More Among Black and Indigenous Americans During COVID-19 Pandemic
As COVID-19 consumed the U.S. in 2020, another health crisis was also raging: the drug overdose epidemic. Nearly 92,000 people died from drug overdoses that year, a 30% increase from 2019. While overdose deaths rose across the population, the increase in deaths was far steeper among Black, American Indian, and Alaska Native people, according to data published July 19 in the U.S. Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report. Overdose deaths rose 44% among Black people from 2019 to 2020, and 39% among American Indian and Alaska Native persons, according to the CDC’s ana...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Drugs healthscienceclimate Source Type: news

FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{ margin:10px 0; padding:0; } table{ border-collapse:collapse; } h1,h2,h3,h4,h5,h6{ display:block; margin:0; padding:0; } img,a img{ border:0; height:auto; outline:none; text-decoration:none; } body,#bodyTable,#bodyCell{ height:100%; margin:0; padding:0; width:100%; } .mcnPreviewText{ display:none !important; } #outlook a{ padding:0; } img{ -ms-interpolation-mode:bicubic; } table{ mso-table-lspace:0pt; mso-table-rspace:0pt; } .ReadMsgBody{ width:100%; } .ExternalClass{ width:100%; } p,a,li,td,blockquote{ ...
Source: Johns Hopkins University and Health Systems Archive - July 13, 2022 Category: Nursing Source Type: news

Suvorexant May Ease Symptoms During Opioid Withdrawal Therapy
Small pilot study suggests suvorexant may improve sleep, reduce opioid withdrawal and craving during buprenorphine/naloxone taper (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 12, 2022 Category: Psychiatry Tags: Pharmacy, Psychiatry, Journal, Source Type: news